Graphite Bio, Inc. - Common Stock (NQ:GRPH)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 21, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	3.150 (1)
Ask (Size)	3.330 (2)
Prev. Close	3.180
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	58,102,949
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 15, 2024

Via Benzinga

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 11, 2024

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart...

Via Benzinga

Performance

More News

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 11, 2024

Via Benzinga

Expert Ratings for Graphite Bio ↗

January 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 11, 2024

Via Benzinga

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket ↗

March 11, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 11, 2024

Via InvestorPlace

GDS Holdings, Coinbase And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 11, 2024

Via Benzinga

Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics

March 08, 2024

From Graphite Bio, Inc.

Via Business Wire

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

February 27, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 05, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. (Nasdaq – CERE), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc.

December 11, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EngageSmart, Inc. (NYSE – ESMT), WaveDancer, Inc. (Nasdaq – WAVD), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

December 04, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hawaiian Holdings, Inc. (Nasdaq – HA), ImmunoGen, Inc. (Nasdaq – IMGN), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

December 04, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

November 27, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

GRAPHITE BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graphite Bio, Inc. - GRPH

November 17, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WaveDancer, Inc. (Nasdaq – WAVD), Selecta Biosciences, Inc. (Nasdaq – SELB), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)

November 16, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

GRPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Graphite Bio, Inc. Is Fair to Shareholders

November 15, 2023

From Halper Sadeh LLC

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 15, 2023

Via Benzinga

LENZ Therapeutics and Graphite Bio Announce Merger Agreement

November 15, 2023

From Graphite Bio, Inc.

Via Business Wire

Graphite Bio Announces Departure of Chief Financial Officer

June 23, 2023

From Graphite Bio, Inc.

Via Business Wire

Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial Results

March 20, 2023

From Graphite Bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023 ↗

February 23, 2023

Via Benzinga

Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring

February 22, 2023

From Graphite Bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023 ↗

January 25, 2023

Via Benzinga

Frequently Asked Questions

Is Graphite Bio, Inc. - Common Stock publicly traded?

Yes, Graphite Bio, Inc. - Common Stock is publicly traded.

What exchange does Graphite Bio, Inc. - Common Stock trade on?

Graphite Bio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Graphite Bio, Inc. - Common Stock?

The ticker symbol for Graphite Bio, Inc. - Common Stock is GRPH on the Nasdaq Stock Market